Compounded medications are not FDA approved. FDA does not review compounded medications for safety, effectiveness, or quality before they are marketed.
Microdose GLP OneMicrodosing evidence & price desk · Updated September 4, 2026

News

Microdose Provider Pricing Changes

Latest — updated September 4, 2026

Price moves on the board this month:

NexLife September 2026 card: tirzepatide $215 → $169 month-to-month, semaglutide $165 → $139

Re-read on NexLife's live plans pages: standard tirzepatide now $169 / $159 / $149 / $139 per month across monthly / 3 / 6 / 12-month terms (from $215 / $195 / $190 / $186) and standard semaglutide $139 / $132 / $125 / $119 (from $165 / $149 / $147 / $145). Microdose tirzepatide announced at $159 → $129 in an August 31 press release, but the program page still showed $189 → $147 on September 4 — recorded as announced. Microdose semaglutide and ODT cards unchanged. Full note: NexLife September 2026 price update.

Trimi and Yucca Health enter the verified all-in set

Trimi's treatment pages publish complete ladders — tirzepatide $235 → $125/mo on a $1,500 annual plan, semaglutide $175 → $99/mo on $1,188, no membership fee — and Yucca Health's tirzepatide page publishes $258 → $225/mo on six months; both read first-party September 4. Trimi now leads both standard categories on 12-month all-in cost; NexLife keeps the lowest month-to-month prices. Ranking: tirzepatide · semaglutide.

Wegovy pill 4 mg offer ends August 31

NovoCare's published pricing keeps the 1.5 mg oral dose at $149/month but steps the 4 mg dose from $149 to $199 after August 31, 2026 — the entry price of the approved-pill lane shifts in three weeks.

Wegovy HD (7.2 mg) cash price: $399/month

The higher-dose semaglutide approved March 19 (≈20.7% average weight loss in STEP UP) sells through NovoCare at $399/month — $50 over standard pens; the $199 two-fill intro continues through December 31.

Monitored category — items publish only when newsworthy and sourced.

The provider-pricing category records verified price changes: old price, new price, effective date, plan, fee, and dose category, each tied to a first-party source capture. Changes flow from and into the provider pricing dataset so the history stays consistent.

Category page indexable; items gated. An item appears here only with a primary source and an event date. We would rather show nothing than manufacture freshness.

What we watch in this category

Primary sources monitored

Not medical advice. This page is consumer education, not medical advice, and does not recommend a dose, product, or provider. Compounded medications are not FDA approved. Talk with a licensed clinician about your situation.